(-0.10%) 5 182.54 points
(0.22%) 38 969 points
(-0.28%) 16 286 points
(0.56%) $78.82
(-1.45%) $2.18
(0.03%) $2 324.90
(0.38%) $27.65
(-0.21%) $986.30
(0.11%) $0.931
(0.02%) $10.90
(0.07%) $0.800
(0.22%) $91.64
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 3.41%
Live Chart Being Loaded With Signals
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments...
Stats | |
---|---|
本日の出来高 | 1.50M |
平均出来高 | 1.40M |
時価総額 | 201.11B |
EPS | INR0 ( 2024-01-28 ) |
次の収益日 | ( INR0 ) 2024-07-26 |
Last Dividend | INR31.00 ( 2023-06-16 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -10.22 |
ATR14 | INR1.756 (0.20%) |
ボリューム 相関
Piramal Enterprises 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Piramal Enterprises 相関 - 通貨/商品
Piramal Enterprises 財務諸表
Annual | 2022 |
収益: | INR47.85B |
総利益: | INR47.67B (99.62 %) |
EPS: | INR603.52 |
FY | 2022 |
収益: | INR47.85B |
総利益: | INR47.67B (99.62 %) |
EPS: | INR603.52 |
FY | 2022 |
収益: | INR138.29B |
総利益: | INR109.93B (79.49 %) |
EPS: | INR80.70 |
FY | 2021 |
収益: | INR128.09B |
総利益: | INR91.53B (71.46 %) |
EPS: | INR56.19 |
Financial Reports:
No articles found.
Piramal Enterprises Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR33.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR31.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.613 | 1996-05-27 |
Last Dividend | INR31.00 | 2023-06-16 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 29 | -- |
Total Paid Out | INR344.88 | -- |
Avg. Dividend % Per Year | 1.59% | -- |
Score | 1.83 | -- |
Div. Sustainability Score | 0.994 | |
Div.Growth Potential Score | 1.681 | |
Div. Directional Score | 1.337 | -- |
Year | Amount | Yield |
---|---|---|
1996 | INR0 | 0.00% |
1997 | INR0 | 0.00% |
1998 | INR0 | 0.00% |
1999 | INR0 | 0.00% |
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR24.40 | 0.99% |
2019 | INR27.33 | 1.17% |
2020 | INR14.00 | 0.91% |
2021 | INR33.00 | 2.23% |
2022 | INR33.00 | 1.23% |
2023 | INR31.00 | 3.70% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
REVATHI.NS | No Dividend Player | 2023-09-27 | Sporadic | 19 | 0.12% | |
KTKBANK.NS | Dividend Junior | 2023-08-22 | Annually | 24 | 2.55% | |
FINPIPE.NS | Dividend Junior | 2023-08-21 | Annually | 23 | 0.73% | |
ANURAS.NS | Dividend Junior | 2023-05-15 | Semi-Annually | 4 | 0.14% | |
TATAMOTORS.NS | Dividend Junior | 2023-07-28 | Sporadic | 29 | 0.14% | |
NOCIL.NS | Dividend Junior | 2023-07-24 | Annually | 19 | 1.11% | |
INDOBORAX.NS | Dividend Junior | 2023-08-11 | Annually | 3 | 0.35% | |
COALINDIA.NS | Dividend King | 2023-08-18 | Semi-Annually | 14 | 6.39% | |
SATIA.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.35% | |
MAHINDCIE.NS | Dividend Junior | 2023-06-02 | Annually | 3 | 0.66% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.307 | 1.500 | -6.14 | -9.21 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.0628 | 1.500 | -1.809 | -2.71 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.730 | 1.000 | -0.470 | -0.470 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.46 | 2.00 | 6.51 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.46 | 2.00 | 4.77 | 9.54 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.828 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.946 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.994 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -11.01 | 1.000 | -1.213 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0628 | 2.50 | -1.163 | -2.71 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.46 | 2.00 | 6.51 | 9.54 | [0 - 30] |
dividendYielPercentageTTM | 3.35 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.46 | 2.00 | 6.51 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.252 | 1.500 | -5.02 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0382 | 1.000 | -1.545 | 0 | [0.1 - 0.5] |
Total Score | 1.681 |
Piramal Enterprises
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides housing finance and other financing solutions, such as private equity, structured debt, senior secured debt, construction finance, and flexi lease rental discounting to real estate sector; and funding solutions to infrastructure, renewable energy, roads, industrials, auto components, and other sectors. It also operates distressed asset investing platform that invests in equity and/or debt in assets. In addition, the company offers contract development and manufacturing solutions, including drug discovery, production, and manufacturing of active pharmaceutical ingredients and formulations; and inhalation and injectable anaesthesia, injectable pain, antibiotics, and other medications, as well as intrathecal spasticity management drugs. Further, it provides over-the-counter products comprising analgesics, skin care, kids' wellness, digestives, women's health, disinfectant, Covifind, and hygiene and protection products, as well as vitamins, minerals, and supplements primarily under the Saridon, Lacto Calamine, Little's, I-Pill, Supradyn, Polycrol, Triactiv, Ourdaily, Pulse Oximeters, and Tetmosol brands. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。